Skip to content

Advertisement

  • Research
  • Open Access

Unmanipulated native fat exposed to high-energy diet, but not autologous grafted fat by itself, may lead to overexpression of Ki67 and PAI-1

  • 1, 2Email author,
  • 3,
  • 4,
  • 1,
  • 4,
  • 3 and
  • 1
SpringerPlus20154:279

https://doi.org/10.1186/s40064-015-1061-0

  • Received: 21 May 2015
  • Accepted: 26 May 2015
  • Published:

Abstract

Background

Although its unclear oncological risk, which led to more than 20 years of prohibition of its use, fat grafting to the breast is widely used nowadays even for aesthetic purposes. Thus, we proposed an experimental model in rats to analyze the inflammatory activity, cellular proliferation and levels of Plasminogen Activator Inhibitor (PAI-1) in grafted fat, and in native fat exposed to high-energy diet in order to study the oncological potential of fat tissue.

Methods

Samples of grafted fat of rats on regular-energy diet were compared with paired samples of native fat from the same rat on regular-energy diet and on high-energy diet in a different time. Analysis involved microscopic comparisons using hematoxylin-eosin staining, immunohistochemistry with anti-CD68-labelled macrophages, and gene expression of Ki-67 and PAI-1.

Results

Hematoxylin-eosin staining analyses did not find any atypical cellular infiltration or unusual tissue types in the samples of grafted fat. The inflammatory status, assessed through immunohistochemical identification of CD68-labelled macrophages, was similar among samples of native fat and grafted fat of rat on regular-energy diet and of native fat of rats on high-energy diet. Real-time PCR revealed that high-energy diet, but not fat grafting, leads to proliferative status on adipose tissue (overexpression of ki-67, p = 0.046) and raised its PAI-1 levels, p < 0.001.

Conclusion

While the native adipose tissue overexpressed PAI-1 and KI67 when exposed to high-energy diet, the grafted fat by itself was unable to induce cellular proliferation, chronic inflammatory activity and/or elevation of PAI-1 levels.

Keywords

  • Fat grafting
  • Breast cancer
  • Lipofilling
  • PAI-1
  • Ki67
  • CD68

Background

In 1895, Czerny described the first breast reconstruction, which was performed with adipose tissue, using a large lipoma from the dorsal flank to fill defects resulted from the excision of a breast benign lesion (Claro et al. 2012). Since then, the adipose tissue (as fat grafting or pedicle flaps from great omentum or subcutaneous tissue) became often used for breast reconstruction (Claro et al. 2012, 2015; Abbott and White 1986; Calderoli and Keiling 1985; Góes 2010; Illouz 1988; Kiricuta 1963). Its popularity though, appeared after the advent of liposuction in the 1970s, when the aspirated fat harvested from many body areas could be reinjected to the breast (Claro et al. 2012). So, the autologous fat grafting began to be used for aesthetic purposes as well, once it is performed using a non-immunogenic substitute/filler, through a versatile and inexpensive procedure obtained usually without donor site morbidity (Claro et al. 2012).

However, it was suggested that adipose tissue might represent an oncological risk for breast cancer, what led the American Society of Plastic Surgeons to prohibit its use to the female breast in 1987 (Claro et al. 2012; ASPRS 1987; Chalmers and Newing 1986). Most of this theory was raised after some studies have correlated the higher potential of breast cancer in obese people (Carter and Church 2009, 2012). Long since great focus to adipose tissue in obesity has been given, such as its comparisons between the omentum and subcutaneous tissue in many disorders like diabetes and cancer (Harman-Boehm et al. 2007; Rodbell 1964; Tam et al. 2012; Weisberg et al. 2003). The most notable hypothesis related to adipocytes and breast cancer is based on the inflammatory potential of these cells, which release adipokines that may lead to chronic inflammation and cell proliferation (once the risk for metabolic disorders and breast cancer seems to be higher in obese people) (Claro et al. 2012, 2015; Chalmers and Newing 1986; Carter and Church 2009, 2012). However, this hypothesis has not been sustained for the procedure of lipofilling to the breast in clinical practice.

Thereupon, the lack of evidence for lipofilling and breast cancer almost 20 years after its prohibition lead to the publication of some case series reporting breast reconstruction with fat grafting in early 2000’s, with good results and without report of higher cancer recurrence than other well established reconstruction procedures (Claro et al. 2012; Góes and Macedo 2006). This demanded in 2009, a review of the prohibition imposed by the American Society of Plastic Surgeons that, owing to lack of evidence, failed to prohibit the use of autologous adipose tissue to the breast, although they do not recommend it (Gutowski and Force 2009).

Since then, many cases series and reviews remain failing to demonstrate higher recurrence rate of breast cancer among women treated with fat grafting (Claro et al. 2012, 2015). So, great effort in experimental field has been made in order to analyze the oncological potential of fat cells to the breast. Some laboratorial studies have focused on adipocytes in vitro, while others have analyzed fat cells from people due to the great difficulty in established an effective experimental model in vivo (Carter and Church 2009, 2012; Baglioni et al. 2009; Baumert et al. 2007; Lin et al. 2001; Wyckoff et al. 2004). Most of these studies even compared fat cells from different fat compartments and/or from people in different conditions, such as obesity and non-obesity. Regarding these issues, great focus to Plasminogen Activator Inhibitor-1 (PAI-1) complex has been taken, because it is a protein found in high concentration in adipose tissue of obese people and/or of breasts with cancer and so, can be used as a marker for them (Carter and Church 2009, 2012; Harman-Boehm et al. 2007; Baglioni et al. 2009; Andreasen et al. 2000; Bianchi et al. 1995; Binder et al. 2002; Cojocaru et al. 2012; Condeelis and Pollard 2006; Dhanasekaran et al. 2012; Di Gregorio et al. 2005; Gomes-Giacoia et al. 2013; Goswami et al. 2005; Gutierrez et al. 2000; Lin et al. 2002; Sumiyoshi et al. 1991). Some of these studies were able to demonstrate the oncological potential of the adipocytes, primary in obese subjects. However, this potential remains uncertain for the procedure of lipofilling to the breast by itself, and was not observed in clinical practice. One believed reason for this, raised by us, is that the breast bed, even after a complete resection of mammary tissue, remains with a large amount of native adipose tissue. So, for locally oncological potential, the adipokines released from transposed/grafted fat cells would be the same of those released from native adipocytes that are already surrounding any remaining mammary glandular cell. And systemically, considering that the donor fat cells are from the same patient that will receive them, the serum concentration of any pro-oncological factor resulting from these adipocytes will remain the same after the procedure.

Moreover, beyond the adipocyte, some theories raised doubts regarding the procedure by itself, due to the great angiogenic potential of the adipose tissue observed in some clinical and experimental studies (Dhanasekaran et al. 2012; Figueiredo et al. 2010; Goldsmith et al. 1967; Liebermann-Meffert 2000; Morison 1903; O’Shaughnessy 1937; Oloumi et al. 2006; Williams and White 1991), that may lead to chronic inflammation and cell proliferation to the microenvironment of lipofilling host site and its surroundings. Thus, there are some issues that must be considered when studying fat grafting: (1) the unpredictable amount of grafted fat present in the sample extracted from the host site, because the long-term graft retention is inaccurate and its absorption can vary from less than 10% to more than 90%; (2) as fat graft is composed not only by adipocytes but also by many other cells and components present in fat tissue, the whole elements of the adipose tissue though, must be analyzed after fat grafting; (3) the grafted tissue must be analyzed in vivo in order to study its behavior in the host site and of its surroundings and; (4) the subjects must be genetically similar and, as controlled as possible, in relation to its diet intake and lifestyle.

Thus, an experimental model was proposed taken into account all the challenges reported above in order to analyze the carcinogenic potential of autologous fat grafting procedure focusing on its main suggested threats to the host site (higher concentration of PAI-1, chronic inflammation activity and higher proliferation rate). We also aimed to compare the findings for this potential resulted from the procedure by itself to those represented by the unmanipulated native fat tissue when exposed to high-energy diet.

Methods

Study design and sample size

A comparative, paired and controlled experimental study was conducted using eight female Sprague–Dawley rats (Rattus norvegicus) from the same dam; obtained at 56-day-old from the Central Reproduction Centre at the State University of Campinas (UNICAMP), Campinas-SP, Brazil. The Sprague–Dawley rat was chosen because it is a breed prone to develop breast cancer when exposed to some risk factors (Russo and Russo 1996; Russo et al. 1983; Shan et al. 2004). Considering that a variable (PAI-1 levels) was used as positive and a negative control for the same tissue of the same rat in different times, a sample size of three rats was defined as enough. However, considering possible exclusions during the evolution of the study, the sample size was set to eight rats.

The study followed the ARRIVE guidelines (Kilkenny et al. 2010) and was approved by the UNICAMP Committee for Ethics in Animal Research (protocol no. 2210-1). The rats remained in the animal-breeding center at the Institute of Biology, UNICAMP from the beginning of the fattening period to the collection of the material for analysis. The rats were housed in isolated boxes that were cleaned daily under a 12-h/day light cycle at a constant temperature of 22 ± 2°C. An overview of the study is summarized in Figure 1.
Figure 1
Figure 1

Flowchart overview of the study. OM unmanipulated native fat tissue of omentum of rats on cafeteria diet regimen (high-energy diet), CO native fat tissue of omentum of rats in regular-energy diet, used as post-operative control, TO grafted fat tissue of omentum of rats in regular-energy diet, SC fragment of unmanipulated native subcutaneous adipose tissue from the left iliac fossa used as control for fat tissue similarity, HE hematoxylin-eosin.

Experimental model proposed and adipose tissue chosen

In order to avoid bias related to the unpredictable amount of grafted fat present in the sample extracted from the host site, an experimental model was proposed using a pedicle fat graft of great omentum, instead of free fat graft from subcutaneous tissue, based on deep study of the literature, and discussions among researchers from some departments of biological institute and medical school at UNICAMP. Although they are from different embryological origin, the adipose tissue from omentum and subcutaneous tissue have the same cellular composition, with similar regenerative and physiological function, and even the same amount of stem cells able to differentiate into any mesenchymal tissue (Cancello et al. 2006; Dicker et al. 2009; Toyoda et al. 2009). A difference identified between these two adipose tissues is the greater metabolic and inflammatory potential of the great omentum if compared to the subcutaneous tissue. These issues are stated as oncogenic risk for breast cancer, what became this model of fat grafting using fat tissue of omentum, instead of subcutaneous, even more sensitive. Thus, in order to avoid bias related to this and false-positive results, a control of native subcutaneous fat of the same rat was used as control for fat tissue similarity.

Dietary regimen and composition of diet

Cafeteria diet was used for 56 days, until the time of great omentum grafting (rats of 112-day-old), so we were able to analyze the carcinogenic potential of high-energy foods consumed by humans in adipose tissue. After the great omentum translocation, the cafeteria diet was replaced for standard rodent chow and water ad libitum for more 56 days (until rats’ age of 168-day-old).

The cafeteria diet consists of replacement of water for soft drinks ad libitum (Coca-cola®) and of standard rodent chow for a pellet made of 37.5% standard rodent chow, 25% peanuts, 25% chocolate, and 12.5% cookies, offered together with wafer, snacks, cakes, and biscuits (4.41 kcal/g, 43.1% from carbohydrates; 12.1% from proteins, and 46.9% from fats). The standard rodent chow diet Nuvilab CR-1 (Nuvital, Brazil) has 2.63 kcal/g (Vanzela et al. 2010). The cafeteria diet was used at the beginning of the study when the rats were younger and so, less prone to bias due to other metabolic disorders related to age. With the cafeteria diet we were able to confirm that the changes in results were only due to the replacement of the diet on the same rat (from high-energy to regular-energy) and so, analyze the influence of diet over the fat tissue and its oncological potential.

Surgical procedure

The rats underwent general anesthesia (intraperitoneally) at 112-day-old. The omentum grafting process was performed through a midline skin incision of approximately 4 cm. Subcutaneous dissection of the entire right hemi-abdomen followed by laparotomy with a 4-cm incision at abdominal midline. The great omentum was divided into three parts (three samples for the study): (1) one was made with 20 mm2 of the left pedicle flap in the left gastroepiploic branch and remained in the abdominal cavity (fat tissue control—CO); (2) a portion of the right flap (also 20 mm2) based on the right gastroepiploic branch was grafted into the subcutaneous layer in the upper right abdomen and fixed to the abdominal wall at its ends with 5.0 nylon (transposed omentum—TO); (3) the remaining central portion of omentum was used to analyze the influence of high-energy diet over fat tissue (omentum on high-energy diet—OM). The abdominal wall was closed with running sutures of 5.0 nylon except the upper 0.3 cm, which was left open for the passage of the translocated omental pedicle. Finally, the skin was closed with running sutures of 5.0 nylon.

The rats were euthanized at 8 weeks post-operatively (168-day-old). Three tissue samples were identified and extracted: native fat tissue of omentum (CO), the grated fat tissue (TO); and a fragment of unmanipulated native subcutaneous adipose tissue (SC) from the left iliac fossa (an area with abundant adipose tissue distant from the manipulated surgical site, thus free from any postoperative inflammatory process).

Histological preparation and analysis

Each sample was immediately identified and introduced into a vial containing 10% buffered formalin. The tissue samples were processed in the pathology laboratory. Sections of 4 μm of each sample were placed on glass slides, dehydrated and stained with hematoxylin-eosin (HE). The evaluation was performed by a single pathologist blinded to the origin of the tissues (with the samples identified only by numbers and letters) with light microscopy, in order to identify the presence of cell populations that differ from the normal cells in the adipose tissue.

Immunohistochemistry

Immunohistochemistry using monoclonal anti-mouse anti-CD68 antibodies (clone Kp-1, Advance, Dako, Glostrup, Denmark) was used to identify the macrophage concentrations in each tissue type (Weisberg, Harman-Boehm) according to the manufacturer’s instructions. A single pathologist, blinded to the origin of each sample, performed the immunohistochemical analysis. The number of anti-CD68 stained macrophages was counted in ten different randomly chosen areas in each processed slide at 40× magnification for each tissue sample. A cell was considered positive when the morphological aspects of a macrophage were observed with a marked cytoplasm outside the vascular lumen (Cancello et al. 2006; Aron-Wisnewsky et al. 2009).

Real-time PCR

Total mRNA extraction was performed using TRIzol® Reagent protocol (Life Technologies, #15596018). Ki67 and PAI-1 mRNA expression were measured in all groups by Real Time PCR (ABI Prism 7500—Applied Biosystems). The primer Ki67 (Rn.PT.58.8428180.g) was obtained from Integrated DNA Technology (IDT), and PAI-1 (Rn01481341_m1) were purchased from Applied Biosystems. GAPDH (#4352339E—Applied Biosystems) was used as endogenous control. Each PCR contained 40 ng of reverse-transcribed RNA, 0.25 μl of each specific primer, Taqman Universal master mix (#4369016—Applied Biosystems), and RNase free water to a 10 μl final volume. Real-time data were analyzed using the Sequence Detector System 7500 (Applied Biosystems).

Statistical analyses

The normal distribution of the data was assessed using the Kolmogorov–Smirnov and Shapiro–Wilk tests. As the data were normally distributed, there were used paired t-test and analysis of variance (ANOVA, one way, and repeated measures) and Tukey test (post hoc) paired t-test for statistical comparisons. The values are given as mean ± standard deviation (SD) and the significance level was 5%. The software used for the analysis was SPSS version 20 for MAC (IBM; Armonk, NY—EUA).

Results

One of the rats died on the 33rd day of high-energy diet, at 89-day-old, before the procedure of adipose tissue grafting. Then, seven rats remained and were used for analyses in this study. A complete healing of the surgical wound with full hair growth at the site was observed at time of samples extraction (rats’ age of 168-day-old). All samples revealed viable flaps under microscopic analysis (without necrosis). No atypical cellular infiltration or unusual tissue types were observed in the samples of grafted fat.

High-energy diet or fat grafting did not influence the inflammatory activity involving CD68 macrophages in fat tissue

Immunohistochemical analyses of the average concentration of CD68-labelled macrophages (Figure 2) in unmanipulated native fat tissue samples of rats fed with high-energy food (OM) was 10.00 ± 4.02 macrophages/field in 10 fields per animal; the average among samples of those fed with standard rodent chow was 10.17 ± 4.17 in control native fat (CO); 6.60 ± 1.75 in grafted fat (TO), and 19.33 ± 5.60 in the subcutaneous fat used as control for fat tissue similarity (SC). What represents that the inflammatory activity involving CD68 macrophages among all the adipose tissue samples were similar p = 0.246 (CI 95% 7.03–16.17), Figure 3.
Figure 2
Figure 2

CD68-labelled macrophages (yellow arrow) in a fat tissue of rats fed with high-energy food (OM) and in b grafted fat of rats in regular-energy diet (TO) (magnification ×400).

Figure 3
Figure 3

Immunohistochemical analyses of the concentration of CD68-labelled macrophages (macrophages/10 fields) per animal in unmanipulated native fat tissue of omentum of rats fed with high-energy food (OM), in native fat tissue of omentum of rats in regular-energy diet (CO), in fat of omentum of rats in regular-energy diet grafted to subcutaneous environment (TO) and in the fat tissue of unmanipulated native subcutaneous adipose tissue from the left iliac fossa (SC).

The high-energy diet represents higher proliferation rate in the adipose tissue environment

The gene expression level of Ki67 (Figure 4a) in the CO samples was 0.52 ± 0.03. A similar pattern was observed in the SC (0.51 ± 0.11) however; the level of 1.20 ± 0.00 was significantly higher in the OM (ANOVA OM vs. CO and SC: p = 0.046, CI 95% 0.41–1.03).
Figure 4
Figure 4

Gene expression level of a Ki67 and b PAI-1. OM unmanipulated native fat tissue of omentum of rats on cafeteria diet regimen (high-energy diet), CO native fat tissue of omentum of rats in regular-energy diet, used as post-operative control, TO grafted fat tissue of omentum of rats in regular-energy diet, SC fragment of unmanipulated native subcutaneous adipose tissue from the left iliac fossa used as control for fat tissue similarity.

The high-energy diet, but not fat grafting procedure, leads to elevation of PAI-1 levels in adipose tissue

Gene expression of PAI-1 (Figure 4b) revealed that its level in the OM of 12.63 ± 3.07 is significantly higher than those identified in CO (1.13 ± 0.32), SC (0.29 ± 0.12) and TO (3.44 ± 1.58), p < 0.001, CI 95% 0.01–6.88. The ANOVA test shows similar low levels of PAI-1 gene expression (p = 0.70) among samples of rats fed with standard rodent chow (CO, TO and SC).

Discussion

Our results showed that the grafted adipose tissue and its surroundings did not expressed inflammatory activity mediated by macrophages, higher cellular proliferation rate nor higher levels of PAI-1. However, high-energy diet leads to higher cellular proliferative rate in the unmanipulated native adipose tissue (analyzed through Ki67) and higher levels of PAI-1.

It is known that the adipose tissue provides a source of stem cells (i.e., cells that are capable of differentiating into other cell types of the same embryonic origin) (Baglioni et al. 2009; Baumert et al. 2007; Dhanasekaran et al. 2012; Oloumi et al. 2006; Kobayashi et al. 2006) and exhibits great angiogenic potential (Figueiredo et al. 2010; Oloumi et al. 2006) for restoring ischemic tissues and actinic lesions (Claro et al. 2012; Illouz 1988; Goldsmith et al. 1967; Liebermann-Meffert 2000; Morison 1903; Williams and White 1991). The movement of this tissue from its primary site to a different environment might expose it to metaplasia. In the present study this theory was not proved, once the histological results using HE did not reveal the presence of cell metaplasia in the TO.

The CD68 is a membrane glycoprotein type 1, strongly expressed by tissue macrophages, present in inflammatory events of vascular and adipose tissues, usually related to fat metabolism. These macrophages have been cited as present in high concentration in adipose tissue of patients with plurimetabolic syndrome and/or insulin-resistance (Di Gregorio et al. 2005), in atherosclerotic plaques (Cojocaru et al. 2012), and in breasts with cancer (with unfavorable impact on disease invasion and progression) (Lin et al. 2001; Wyckoff et al. 2004; Condeelis and Pollard 2006; Goswami et al. 2005; Lin et al. 2002; Piras et al. 2005; Soeda et al. 2008; Offersen et al. 2003). However, according to our findings, no connection was identified in literature between the level of CD68-labelled macrophages and obesity in patients without any metabolic disorder (Tam et al. 2012; Di Gregorio et al. 2005). What represents that those macrophages levels in a tissue depend of inflammatory events and pathological chemotaxis from sick adipocyte mediators but not from healthy adipose tissue. In this study, the CD68 antigen was used to identify the chemotaxis potential of adipose tissue to attract CD68-labelled macrophages, which may represent a risk for breast cancer and/or its unfavorable evolution (Lin et al. 2001; Wyckoff et al. 2004; Condeelis and Pollard 2006; Goswami et al. 2005; Lin et al. 2002; Piras et al. 2005; Soeda et al. 2008).

Di Gregorio et al. (2005) have shown that the CD68 expression is also higher at the stromal vascular fraction of the adipose tissue than its adipocyte fraction. Considering that the angiogenesis is intense just after adipose tissue grafting or translocation (Figueiredo et al. 2010), what represents one among many theories for its potential for breast cancer, a chronic higher concentration of CD68-labelled macrophage was expected. However, this data was not found in this study and the CD68 expression was similar in all adipose tissue samples. Therefore, adipose tissue grafting does not seem to generate chronic inflammatory activity involving CD68 macrophages that may lead to a carcinogenic potential in its host microenvironment.

Ki67 is a nuclear protein present in proliferating cells, but absent in resting cells. What means that ki67 is associated with cell proliferation (Gerdes et al. 1984; Pathmanathan and Balleine 2013; Rahmanzadeh et al. 2007). Nowadays, Ki67 scoring is used as a prognostic factor for early breast cancer and even as a predictor of its treatment efficacy (Pathmanathan and Balleine 2013; Urruticoechea et al. 2005; Bullwinkel et al. 2006; Luporsi et al. 2012; Inwald et al. 2013; Nishimura et al. 2010). The gene expression of Ki67 was used in order to evaluate the proliferation rate of adipose tissue from different body compartments, as well as its behavior on high-energy diet and after its translocation to a different environment. The possibility of transposed fat creating a proliferative status in the host microenvironment is considered mostly due to the knowledge that the adipose tissue promotes angiogenesis, deeply explored in the great omentum experiments (Baumert et al. 2007; Figueiredo et al. 2010; Goldsmith et al. 1967; O’Shaughnessy 1937; Oloumi et al. 2006), what theoretically may represent another threat for breast cancer. In this study, the adipose tissue per se, did not show any change in its proliferative rate according to its origin site or after its translocation to a different environment. However, a proliferative status was observed on samples of unmanipulated native fat exposed to a high-energy dietary regimen.

Plasminogen Activator Inhibitor 1 is a single-chain glycoprotein that acts as the primary regulator of plasminogen activation in vivo. It is secreted by several cells and participates in tissue repair processes (Binder et al. 2002; Gomes-Giacoia et al. 2013; Sumiyoshi et al. 1991; Jankun et al. 1993). High PAI-1 level correlates with obesity, hyperinsulinemia, hyperglycemia, and hypertriglyceridemia (Carter and Church 2009; Binder et al. 2002). Some oncological conditions show high level of PAI-1 as well. Its role in breast cancer has been widely studied, where it is involved in the decrease of apoptotic activity, degradation of extracellular matrix during tumor growth, invasion, and metastasis. High levels of PAI-1 in breast cancer thus, is linked to the poor prognosis of disease progression (Carter and Church 2009, 2012; Andreasen et al. 2000; Bianchi et al. 1995; Gomes-Giacoia et al. 2013; Gutierrez et al. 2000; Sumiyoshi et al. 1991; Offersen et al. 2003; Jankun et al. 1993; Foekens et al. 2000). Our study found high levels of PAI-1 only on unmanipulated adipose tissue samples of rats fed with high-energy food, which posteriorly became low in the same rats after change of their diet regimen. Carter and Church (2012) demonstrated that the native mature fat cells of breast seems to represent a greater threat to breast cancer than fat cells from other regions and, even higher than immature adipocytes or stem cells. In addition, fat cells are widely present in our body and there is no evidence that a fat grafting procedure by itself would bring additional oncological risk to a region that is already surrounded by adipose tissue.

Conclusion

We found in this study in rats that, while the unmanipulated native adipose tissue overexpressed PAI-1 and KI67 when exposed to high-energy diet, the grafted fat by itself was unable to induce cellular proliferation, chronic inflammatory activity and/or elevation of PAI-1 levels. This findings highlight that fat grafting procedure alone does not seem to change the oncological potential of its host microenvironment, however more experimental studies focusing on the fat grafting behavior in vivo must be made in order to confirm this issue.

Declarations

Authors’ contributions

FCJR conceived the study and its design, participated in analysis and interpretation of data, performed the statistical analysis and drafted of manuscript. LRM carried out the immunoassays and helped to draft the manuscript. JM carried out the molecular genetic studies, participated in the sequence alignment and helped to draft the manuscript. LOZS participated in analysis and interpretation of data, helped with the statistical analysis and to draft of manuscript, GAP carried out the immunoassays and interpretation of data. LAV carried out the molecular genetic studies and participated in interpretation of data, AMPN participated in the study conception, design, interpretation of data and coordination. All authors read and approved the final manuscript.

Acknowledgements

This research was supported by the salary provided by “Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)”, a Brazilian federal institution for post graduation programmes, to Dr. Claro Jr. The authors thank Emerielle C. Vanzela for her important contribution with rats’ care and procedures assistance and technical laboratorial orientation, Antônio C. Boschero for the rats donation and for the support with the Laboratory of Physiology and Biophysics of the Institute of Biology at State University of Campinas.

Compliance with ethical guidelines

Competing interests The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Department of Gynecology and Obstetrics at School of Medical Sciences, State University of Campinas (UNICAMP), R. Alexander Fleming, 101, Campinas, SP, 13083-881, Brazil
(2)
Santa Cruz Plastic Surgery Institute (ICPSC), São Paulo, SP, Brazil
(3)
Laboratory of Cell Signaling, Obesity and Comorbidities Research Center, State University of Campinas (UNICAMP), Campinas, SP, Brazil
(4)
Laboratory of Specialized Pathology, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, SP, Brazil

References

  1. Abbott W, White H (1986) Omental transposition for recurrent breast carcinoma following limited surgical excision and radiation therapy. Eur J Surg Oncol 12(1):59–66Google Scholar
  2. Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57(1):25–40View ArticleGoogle Scholar
  3. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A et al (2009) Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94(11):4619–4623View ArticleGoogle Scholar
  4. ASPRS (1987) Report on autologous fat transplantation. ASPRS Ad-Hoc Committee on New Procedures. Plast Surg Nurs Nurs 7:140Google Scholar
  5. Baglioni S, Francalanci M, Squecco R, Lombardi A, Cantini G, Angeli R et al (2009) Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 23(10):3494–3505View ArticleGoogle Scholar
  6. Baumert H, Simon P, Hekmati M, Fromont G, Levy M, Balaton A et al (2007) Development of a seeded scaffold in the great omentum: feasibility of an in vivo bioreactor for bladder tissue engineering. Eur Urol 52(3):884–890View ArticleGoogle Scholar
  7. Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, Smith HS (1995) Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer (Journal international du cancer) 60(5):597–603View ArticleGoogle Scholar
  8. Binder BR, Christ G, Gruber F, Grubic N, Hufnagl P, Krebs M et al (2002) Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17:56–61Google Scholar
  9. Bullwinkel J, Baron-Luhr B, Ludemann A, Wohlenberg C, Gerdes J, Scholzen T (2006) Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206(3):624–635View ArticleGoogle Scholar
  10. Calderoli H, Keiling R (1985) Covering of substantial loss of substance in breast cancer with local complications. Apropos of 57 cases. Acta Chir Belg 85(1):1–8Google Scholar
  11. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D et al (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55(6):1554–1561View ArticleGoogle Scholar
  12. Carter JC, Church FC (2009) Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-gamma and plasminogen activator inhibitor-1. PPAR Res 2009:345320Google Scholar
  13. Carter JC, Church FC (2012) Mature breast adipocytes promote breast cancer cell motility. Exp Mol Pathol 92(3):312–317View ArticleGoogle Scholar
  14. Chalmers P, Newing R (1986) Influence of omentum transposition on experimental tumors. J Surg Oncol 32(3):135–137View ArticleGoogle Scholar
  15. Claro F Jr, Sarian LOZ, Pinto-Neto AM (2015) Omentum for mammary disorders—a 30-year systematic review. Ann Surg Oncol 22(8). doi:10.1245/s10434-014-4328-8
  16. Claro F Jr, Figueiredo JCA, Zampar AG, Pinto-Neto AM (2012) Applicability and safety of autologous fat for reconstruction of the breast. Br J Surg 99(6):768–780View ArticleGoogle Scholar
  17. Cojocaru E, Trandafirescu M, Leon M, Cotutiu C, Foia L (2012) Immunohistochemical expression of anti-CD68 antibody in atherosclerotic plaque. Rom J Morphol Embryol (Revue roumaine de morphologie et embryologie) 53(1):61–66Google Scholar
  18. Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266View ArticleGoogle Scholar
  19. Dhanasekaran M, Indumathi S, Kanmani A, Poojitha R, Revathy KM, Rajkumar JS et al (2012) Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow. Cytotechnology 64(5):497–509View ArticleGoogle Scholar
  20. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM et al (2005) Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54(8):2305–2313View ArticleGoogle Scholar
  21. Dicker A, Astrom G, Wahlen K, Hoffstedt J, Naslund E, Wiren M et al (2009) Primary differences in lipolysis between human omental and subcutaneous adipose tissue observed using in vitro differentiated adipocytes. Horm Metab Res (Hormon- und Stoffwechselforschung = Hormones et metabolisme) 41(5):350–355View ArticleGoogle Scholar
  22. Figueiredo JCA, Naufal RR, Claro F Jr, Arias V, Pereira PRB, Cirino LMI (2010) Prefabricated flap composed by skin and terminal gastromental vessels. Experimental study in rabbits. J Plast Reconstr Aesthet Surg 63(6):e525–e528View ArticleGoogle Scholar
  23. Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD et al (2000) The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res 60(3):636–643Google Scholar
  24. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4):1710–1715Google Scholar
  25. Góes JCS (2010) Aesthetic improvements in Poland’s syndrome treatment with omentum flap. Aesthet Plast Surg 34(5):640–641View ArticleGoogle Scholar
  26. Góes J, Macedo A (2006) Immediate reconstruction after skin-sparing mastectomy using omental flap and synthetic mesh. In: Spear S (ed) Surgery of the breast: principles and art. Lippincott, Philadelphia, pp 786–793Google Scholar
  27. Goldsmith HS, De los Santos R, Beattie EJ Jr (1967) Relief of chronic lymphedema by omental transposition. Ann Surg 166(4):573–585View ArticleGoogle Scholar
  28. Gomes-Giacoia E, Miyake M, Goodison S, Rosser CJ (2013) Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model. Mol Cancer Ther 12(12):2697–2708View ArticleGoogle Scholar
  29. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, Pixley FJ et al (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65(12):5278–5283View ArticleGoogle Scholar
  30. Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ (2000) Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res 60(20):5839–5847Google Scholar
  31. Gutowski KA, Force AFGT (2009) Current applications and safety of autologous fat grafts: a report of the ASPS fat graft task force. Plast Reconstr Surg 124(1):272–280View ArticleGoogle Scholar
  32. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metabol 92(6):2240–2247View ArticleGoogle Scholar
  33. Illouz YG (1988) Present results of fat injection. Aesthet Plast Surg 12(3):175–181View ArticleGoogle Scholar
  34. Inwald EC, Klinkhammer-Schalke M, Hofstadter F, Zeman F, Koller M, Gerstenhauer M et al (2013) Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 139(2):539–552View ArticleGoogle Scholar
  35. Jankun J, Merrick HW, Goldblatt PJ (1993) Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 53(2):135–144View ArticleGoogle Scholar
  36. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother 1(2):94–99View ArticleGoogle Scholar
  37. Kiricuta I (1963) Lemploi du grand épiploon dans la chirurgie du sein cancéreux. In: Masson EDiteur 120 Blvd Saint-Germain, 75280 Paris 06, France, vol 71, pp 15–17Google Scholar
  38. Kobayashi T, Aomatsu Y, Iwata H, Kin T, Kanehiro H, Hisanga M et al (2006) Survival of microencapsulated islets at 400 days posttransplantation in the omental pouch of NOD mice. Cell Transplt 15(4):359–365View ArticleGoogle Scholar
  39. Liebermann-Meffert D (2000) The greater omentum. Anatomy, embryology, and surgical applications. Surg Clin N Am 80(1):275–293 (xii) View ArticleGoogle Scholar
  40. Lin EY, Nguyen AV, Russell RG, Pollard JW (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193(6):727–740View ArticleGoogle Scholar
  41. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW (2002) The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7(2):147–162View ArticleGoogle Scholar
  42. Luporsi E, Andre F, Spyratos F, Martin PM, Jacquemier J, Penault-Llorca F et al (2012) Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat 132(3):895–915View ArticleGoogle Scholar
  43. Morison R (1903) A case of ascites due to liver cirrhosis treated by Operation. Ann Surg 38(3):361–366View ArticleGoogle Scholar
  44. Nishimura R, Osako T, Okumura Y, Hayashi M, Toyozumi Y, Arima N (2010) Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Ther Med 1(5):747–754View ArticleGoogle Scholar
  45. O’Shaughnessy L (1937) Surgical treatment of cardiac ischmæmia. Lancet 229(5917):185–194View ArticleGoogle Scholar
  46. Offersen BV, Nielsen BS, Hoyer-Hansen G, Rank F, Hamilton-Dutoit S, Overgaard J et al (2003) The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol 163(5):1887–1899View ArticleGoogle Scholar
  47. Oloumi MM, Derakhshanfar A, Molaei MM, Tayyebi M (2006) The angiogenic potential of autogenous free omental graft in experimental tibial defects in rabbit: short-term preliminary histopathological study. J Exp Anim Sci 43(3):179–187View ArticleGoogle Scholar
  48. Pathmanathan N, Balleine RL (2013) Ki67 and proliferation in breast cancer. J Clin Pathol 66(6):512–516View ArticleGoogle Scholar
  49. Piras F, Colombari R, Minerba L, Murtas D, Floris C, Maxia C et al (2005) The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer 104(6):1246–1254View ArticleGoogle Scholar
  50. Rahmanzadeh R, Huttmann G, Gerdes J, Scholzen T (2007) Chromophore-assisted light inactivation of pKi-67 leads to inhibition of ribosomal RNA synthesis. Cell Prolif 40(3):422–430View ArticleGoogle Scholar
  51. Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380Google Scholar
  52. Russo IH, Russo J (1996) Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104(9):938–967View ArticleGoogle Scholar
  53. Russo J, Tait L, Russo IH (1983) Susceptibility of the mammary gland to carcinogenesis. III. The cell of origin of rat mammary carcinoma. Am J Pathol 113(1):50–66Google Scholar
  54. Shan L, Yu M, Schut HA, Snyderwine EG (2004) Susceptibility of rats to mammary gland carcinogenesis by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) varies with age and is associated with the induction of differential gene expression. Am J Pathol 165(1):191–202View ArticleGoogle Scholar
  55. Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H et al (2008) Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol 109(1):122–128View ArticleGoogle Scholar
  56. Sumiyoshi K, Baba S, Sakaguchi S, Urano T, Takada Y, Takada A (1991) Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb Res 63(1):59–71View ArticleGoogle Scholar
  57. Tam CS, Sparks LM, Johannsen DL, Covington JD, Church TS, Ravussin E (2012) Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects. Obesity 20(7):1530–1533View ArticleGoogle Scholar
  58. Toyoda M, Matsubara Y, Lin K, Sugimachi K, Furue M (2009) Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omental adipose tissues. Cell Biochem Funct 27(7):440–447View ArticleGoogle Scholar
  59. Urruticoechea A, Smith IE, Dowsett M (2005) Proliferation marker Ki-67 in early breast cancer. J Clin Oncol 23(28):7212–7220View ArticleGoogle Scholar
  60. Vanzela EC, Ribeiro RA, de Oliveira CA, Rodrigues FB, Bonfleur ML, Carneiro EM et al (2010) Pregnancy restores insulin secretion from pancreatic islets in cafeteria diet-induced obese rats. Am J Physiol Regul Integr Comp Physiol 298(2):R320–328View ArticleGoogle Scholar
  61. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig 112(12):1796–1808View ArticleGoogle Scholar
  62. Williams RJ, White H (1991) Transposition of the greater omentum in the prevention and treatment of radiation injury. Neth J Surg 43(5):161–166Google Scholar
  63. Wyckoff J, Wang WG, Lin EY, Wang YR, Pixley F, Stanley ER et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022–7029View ArticleGoogle Scholar

Copyright

Advertisement